These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9851546)
1. Modulation by lipid mediators of immune complex-induced lung inflammation in mice. Steil AA; Tavares de Lima W; Jancar S Eur J Pharmacol; 1998 Nov; 361(1):93-9. PubMed ID: 9851546 [TBL] [Abstract][Full Text] [Related]
2. Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Tavares de Lima W; Steil AA; Russo M; Starobinas N; Teixeira CF; Jancar S Eur J Pharmacol; 1998 Sep; 358(1):69-75. PubMed ID: 9809871 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. Steil AA; Teixeira CF; Jancar S Prostaglandins Other Lipid Mediat; 1999 Jan; 57(1):35-48. PubMed ID: 10367295 [TBL] [Abstract][Full Text] [Related]
4. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. de Lima WT; Sirois P; Jancar S Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472 [TBL] [Abstract][Full Text] [Related]
5. Involvement of eicosanoids and PAF in immune-complex alveolitis. Tavares-de-Lima W; Teixeira CF; Sirois P; Jancar S Braz J Med Biol Res; 1989; 22(6):745-8. PubMed ID: 2620187 [TBL] [Abstract][Full Text] [Related]
6. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685 [TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. Lee YM; Hybertson BM; Cho HG; Repine JE J Lab Clin Med; 2002 Nov; 140(5):312-9. PubMed ID: 12434132 [TBL] [Abstract][Full Text] [Related]
8. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats. Rocha FA; Andrade LE; Russo M; Jancar S J Lipid Mediat Cell Signal; 1997 May; 16(1):1-10. PubMed ID: 9101418 [TBL] [Abstract][Full Text] [Related]
9. Roles of endothelins and their receptors in immune complex-induced/polymorphonuclear-mediated lung injury (reversed passive arthus reaction) in CD-1 mice. Battistini B; Steil AA; Jancar S; Sirois P Pulm Pharmacol Ther; 1998; 11(2-3):165-72. PubMed ID: 9918750 [TBL] [Abstract][Full Text] [Related]
10. Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor. Olson NC; Kruse-Elliott KT; Johnson LW Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):549-59. PubMed ID: 8415804 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. Bozza PT; Payne JL; Goulet JL; Weller PF J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909 [TBL] [Abstract][Full Text] [Related]
12. The 5-lipoxygenase pathway is required for acute lung injury following hemorrhagic shock. Eun JC; Moore EE; Mauchley DC; Johnson CA; Meng X; Banerjee A; Wohlauer MV; Zarini S; Gijón MA; Murphy RC Shock; 2012 Jun; 37(6):599-604. PubMed ID: 22392149 [TBL] [Abstract][Full Text] [Related]
13. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats. Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies. Silbaugh SA; Stengel PW; Cockerham SL; Froelich LL; Bendele AM; Spaethe SM; Sofia MJ; Sawyer JS; Jackson WT Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):397-404. PubMed ID: 10763854 [TBL] [Abstract][Full Text] [Related]
15. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. Provost P; Borgeat P; Merhi Y Br J Pharmacol; 1998 Jan; 123(2):251-8. PubMed ID: 9489613 [TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: contribution of neutrophils and endogenous mediators. Teixeira MM; Fairbairn SM; Norman KE; Williams TJ; Rossi AG; Hellewell PG Br J Pharmacol; 1994 Dec; 113(4):1363-71. PubMed ID: 7889293 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
18. Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits. Herd CM; Donigi-Gale D; Shoupe TS; Page CP Br J Pharmacol; 1992 Dec; 107(4):1108-15. PubMed ID: 1467833 [TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Quinn JV; Slotman GJ Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Landgraf RG; Nossi DF; Sirois P; Jancar S Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]